[Comparative study (tolerance and effectiveness) of classic antituberculous therapy (P.A.S.-streptomycin-isoniazid) and a new combination (prothionamide-streptomycin-isoniazid)].
D000284:Administration, Oral; D000577:Amides / Q000008:administration & dosage; D000636:Aminosalicylic Acids / Q000008:administration & dosage*; D004338:Drug Combinations; D006801:Humans; D007275:Injections, Intravenous; D007538:Isoniazid / Q000008:administration & dosage*; D007539:Isonicotinic Acids / Q000008:administration & dosage*; D013307:Streptomycin / Q000008:administration & dosage*; D013440:Sulfides / Q000008:administration & dosage; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000577:Amides; D000636:Aminosalicylic Acids; D004338:Drug Combinations; D007539:Isonicotinic Acids; D013440:Sulfides; D007538:Isoniazid; D013307:Streptomycin
Etude comparée (tolérance et efficacité) du traitement antituberculeux classique (.A.S.-streptomycine-isoniazide) et d'une nouvelle association (prothionamide-streptomycine-isoniazide.